4//SEC Filing
O'Kane Kieran 4
Accession 0000905148-25-000780
CIK 0001439725other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:32 PM ET
Size
9.8 KB
Accession
0000905148-25-000780
Insider Transaction Report
Form 4
BIODESIX INCBDSX
O'Kane Kieran
Chief Commercial Officer
Transactions
- Award
Stock Options (Right to buy)
2025-02-20+87,319→ 87,319 totalExercise: $0.92Exp: 2035-02-19→ Common Stock (87,319 underlying) - Award
Restricted Stock Units
2025-02-20+117,500→ 117,500 total→ Common Stock (117,500 underlying) - Award
Stock Options (Right to buy)
2025-02-20+235,000→ 235,000 totalExercise: $0.92Exp: 2035-02-19→ Common Stock (235,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
- [F3]This option vests in a series of forty-eight successive equal monthly installments measured from February 20, 2025, generally subject to the Reporting Person's continuous service through each applicable vesting date.
- [F4]This option vested in full on February 20, 2025. Under the Issuer's 2024 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2024 in the form of a fully-vested option.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001828131
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:32 PM ET
- Size
- 9.8 KB